|
US5410017A
(en)
*
|
1993-05-21 |
1995-04-25 |
Rohm And Haas Company |
Continuous thermal polycondensation process for preparing polypeptide polymers
|
|
DK2191001T3
(en)
|
2007-04-09 |
2016-09-19 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
US10294281B2
(en)
|
2012-05-15 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
High-transduction-efficiency rAAV vectors, compositions, and methods of use
|
|
US12358954B2
(en)
|
2012-05-15 |
2025-07-15 |
University Of Florida Research Foundation, Incorporated |
Capsid-modified rAAV vector compositions and methods therefor
|
|
WO2015048534A1
(en)
|
2013-09-26 |
2015-04-02 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
WO2016126857A1
(en)
|
2015-02-03 |
2016-08-11 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
|
GB201508026D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
BR112018003665A2
(en)
|
2015-09-28 |
2018-09-25 |
The University Of North Carolina At Chapel Hill |
methods and compositions for antibody evasion viral vectors
|
|
WO2017070476A2
(en)
*
|
2015-10-22 |
2017-04-27 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav3 capsid library
|
|
EP4659816A3
(en)
*
|
2015-12-14 |
2025-12-31 |
The University of North Carolina at Chapel Hill |
MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY
|
|
US20190262373A1
(en)
*
|
2016-08-16 |
2019-08-29 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
WO2018035503A1
(en)
*
|
2016-08-18 |
2018-02-22 |
The Regents Of The University Of California |
Crispr-cas genome engineering via a modular aav delivery system
|
|
AU2018224044B2
(en)
|
2017-02-21 |
2024-01-25 |
The Uab Research Foundation |
Modified AAV capsid proteins and uses thereof
|
|
AU2018261769B2
(en)
|
2017-05-05 |
2024-03-14 |
The Regents Of The University Of California |
Compositions and methods for expressing Otoferlin
|
|
MX2020000244A
(es)
*
|
2017-06-27 |
2020-09-28 |
Regeneron Pharma |
Vectores virales recombinantes con tropismo modificado y usos de estos para la introduccion dirigida de material genetico a celulas humanas.
|
|
AU2018330208B2
(en)
*
|
2017-09-08 |
2025-04-17 |
Generation Bio Co. |
Lipid nanoparticle formulations of non-viral, capsid-free DNA vectors
|
|
KR20200122320A
(ko)
|
2018-01-16 |
2020-10-27 |
씨엘에스 테라퓨틱스 리미티드 |
데옥시리보뉴클레아제 (dnase) 활성을 갖는 효소의 간 발현에 의한 질환의 치료
|
|
SG11202006056RA
(en)
*
|
2018-01-17 |
2020-07-29 |
Meiragtx Uk Ii Ltd |
A modified raav capsid protein for gene therapy
|
|
CN111902164A
(zh)
|
2018-02-01 |
2020-11-06 |
同源药物公司 |
用于恢复pah基因功能的腺相关病毒组合物及其使用方法
|
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
|
EP3749771A1
(en)
*
|
2018-02-07 |
2020-12-16 |
Genethon |
Hybrid regulatory elements
|
|
CN112041437A
(zh)
|
2018-02-19 |
2020-12-04 |
同源药物公司 |
用于恢复f8基因功能的腺相关病毒组合物和其使用方法
|
|
US20210032660A1
(en)
*
|
2018-03-29 |
2021-02-04 |
Asklepios Biopharmaceutical, Inc. |
Liver tropic recombinant aav6 vectors that evade neutralization
|
|
CN112543766A
(zh)
|
2018-04-03 |
2021-03-23 |
斯特里迪比奥公司 |
抗体逃避性病毒载体
|
|
CA3094465A1
(en)
|
2018-04-03 |
2019-10-10 |
Stridebio, Inc. |
Virus vectors for targeting ophthalmic tissues
|
|
US20210363191A1
(en)
|
2018-04-03 |
2021-11-25 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
WO2019210267A2
(en)
*
|
2018-04-27 |
2019-10-31 |
Spark Therapeutics, Inc. |
Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using same
|
|
CN119410636A
(zh)
|
2018-04-27 |
2025-02-11 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
JP7142815B2
(ja)
*
|
2018-06-21 |
2022-09-28 |
株式会社遺伝子治療研究所 |
ヒト肝臓への遺伝子導入のためのアデノ随伴ウイルスビリオン
|
|
CN112703198B
(zh)
|
2018-07-11 |
2025-05-30 |
布里格姆妇女医院 |
用于跨血脑屏障递送试剂的方法和组合物
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
WO2020079256A1
(en)
*
|
2018-10-19 |
2020-04-23 |
Genethon |
Modulation, monitoring and prediction of the immune response directed against aav gene therapy vectors
|
|
WO2020148458A1
(en)
*
|
2019-01-18 |
2020-07-23 |
Institut Pasteur |
Aav-mediated gene therapy restoring the otoferlin gene
|
|
AU2020218547A1
(en)
|
2019-02-08 |
2021-08-26 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
BR112021018776A2
(pt)
|
2019-03-21 |
2021-11-30 |
Stridebio Inc |
Vetores de vírus adenoassociado recombinante
|
|
EP3736330A1
(en)
*
|
2019-05-08 |
2020-11-11 |
European Molecular Biology Laboratory |
Modified adeno-associated virus (aav) particles for gene therapy
|
|
AU2020299026A1
(en)
*
|
2019-07-04 |
2022-01-20 |
Children's Medical Research Institute |
Methods and AAV vectors for in vivo transduction
|
|
WO2021005210A1
(en)
*
|
2019-07-11 |
2021-01-14 |
Centre National De La Recherche Scientifique |
Chemically-modified adeno-associated virus
|
|
WO2021050974A1
(en)
*
|
2019-09-12 |
2021-03-18 |
The Broad Institute, Inc. |
Engineered adeno-associated virus capsids
|
|
KR20220083714A
(ko)
|
2019-10-17 |
2022-06-20 |
스트라이드바이오 인코포레이티드 |
니만-피크 질환 c형의 치료를 위한 아데노-연관 바이러스 벡터
|
|
CA3159549A1
(en)
|
2019-10-30 |
2021-05-06 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
US20230340526A1
(en)
*
|
2019-11-25 |
2023-10-26 |
University Of Florida Research Foundation, Incorporated |
Novel aav3b variants that target hepatocytes and evade the humoral immune response
|
|
WO2021108468A1
(en)
*
|
2019-11-25 |
2021-06-03 |
University Of Florida Research Foundation, Incorporated |
Novel aav3b variants that target human hepatocytes in the liver of humanized mice
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
AU2021247172A1
(en)
|
2020-04-01 |
2022-09-15 |
University Of Florida Research Foundation, Incorporated |
Dual AAV-MY07A vectors with improved safety for the treatment of USH1B
|
|
US12209251B2
(en)
|
2020-05-05 |
2025-01-28 |
The University Of North Carolina At Chapel Hill |
Modified adeno-associated virus 5 capsids and uses thereof
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
EP4200408A1
(en)
|
2020-08-19 |
2023-06-28 |
Sarepta Therapeutics, Inc. |
Adeno-associated virus vectors for treatment of rett syndrome
|
|
CA3201533A1
(en)
|
2020-11-11 |
2022-05-19 |
European Molecular Biology Laboratory |
Modified viral particles for gene therapy
|
|
CN113647359A
(zh)
*
|
2021-08-15 |
2021-11-16 |
芜湖职业技术学院 |
注射衣霉素诱导急性肝损伤小鼠模型的构建方法
|
|
WO2023072181A1
(en)
*
|
2021-10-28 |
2023-05-04 |
Shanghai Vitalgen Biopharma Co., Ltd. |
Adeno-associated virus capsid
|
|
WO2023201368A2
(en)
*
|
2022-04-15 |
2023-10-19 |
Dyno Therapeutics, Inc. |
Capsid variants and methods of using the same
|
|
GB202407863D0
(en)
|
2024-06-03 |
2024-07-17 |
Purespring Therapeutics Ltd |
Methods
|
|
WO2026001958A1
(zh)
*
|
2024-06-24 |
2026-01-02 |
黄菁 |
Aav载体、aav载体的组合、构建aml pdx和mm pdx非人动物的方法及构建免疫系统人源化非人动物的方法
|
|
CN119380820B
(zh)
*
|
2024-10-10 |
2025-06-17 |
四川大学华西医院 |
一种aav2衣壳蛋白变体设计方法、系统和存储介质
|